The Role of Ataxia Telangiectasia Mutant and Rad3-Related DNA Damage Response in Pathogenesis of Human Papillomavirus
- PMID: 32585979
- PMCID: PMC7350315
- DOI: 10.3390/pathogens9060506
The Role of Ataxia Telangiectasia Mutant and Rad3-Related DNA Damage Response in Pathogenesis of Human Papillomavirus
Abstract
Human papillomavirus (HPV) infection leads to a variety of benign lesions and malignant tumors such as cervical cancer and head and neck squamous cell carcinoma. Several HPV vaccines have been developed that can help to prevent cervical carcinoma, but these vaccines are only effective in individuals with no prior HPV infection. Thus, it is still important to understand the HPV life cycle and in particular the association of HPV with human pathogenesis. HPV production requires activation of the DNA damage response (DDR), which is a complex signaling network composed of multiple sensors, mediators, transducers, and effectors that safeguard cellular DNAs to maintain the host genome integrity. In this review, we focus on the roles of the ataxia telangiectasia mutant and Rad3-related (ATR) DNA damage response in HPV DNA replication. HPV can induce ATR expression and activate the ATR pathway. Inhibition of the ATR pathway results in suppression of HPV genome maintenance and amplification. The mechanisms underlying this could be through various molecular pathways such as checkpoint signaling and transcriptional regulation. In light of these findings, other downstream mechanisms of the ATR pathway need to be further investigated for better understanding HPV pathogenesis and developing novel ATR DDR-related inhibitors against HPV infection.
Keywords: DNA damage response (DDR); HPV DNA replication; Human papillomavirus (HPV); cervical cancer; genome amplification; life cycle; the ATR pathway.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
STAT-5 Regulates Transcription of the Topoisomerase IIβ-Binding Protein 1 (TopBP1) Gene To Activate the ATR Pathway and Promote Human Papillomavirus Replication.mBio. 2015 Dec 22;6(6):e02006-15. doi: 10.1128/mBio.02006-15. mBio. 2015. PMID: 26695634 Free PMC article.
-
Why Human Papillomaviruses Activate the DNA Damage Response (DDR) and How Cellular and Viral Replication Persists in the Presence of DDR Signaling.Viruses. 2017 Sep 21;9(10):268. doi: 10.3390/v9100268. Viruses. 2017. PMID: 28934154 Free PMC article. Review.
-
Modulation of the DNA damage response during the life cycle of human papillomaviruses.Virus Res. 2017 Mar 2;231:41-49. doi: 10.1016/j.virusres.2016.11.006. Epub 2016 Nov 9. Virus Res. 2017. PMID: 27836727 Free PMC article. Review.
-
Pathogenesis of Human Papillomaviruses Requires the ATR/p62 Autophagy-Related Pathway.mBio. 2020 Aug 12;11(4):e01628-20. doi: 10.1128/mBio.01628-20. mBio. 2020. PMID: 32788179 Free PMC article.
-
FANCD2 Binds Human Papillomavirus Genomes and Associates with a Distinct Set of DNA Repair Proteins to Regulate Viral Replication.mBio. 2017 Feb 14;8(1):e02340-16. doi: 10.1128/mBio.02340-16. mBio. 2017. PMID: 28196964 Free PMC article.
Cited by
-
Pharmacologic inhibition of ataxia telangiectasia and Rad3-related (ATR) in the treatment of head and neck squamous cell carcinoma.Mol Carcinog. 2022 Feb;61(2):225-238. doi: 10.1002/mc.23384. Epub 2021 Dec 29. Mol Carcinog. 2022. PMID: 34964992 Free PMC article. Review.
References
-
- Chelmow D. Practice bulletin No. 168: Cervical cancer screening and prevention. Obstet. Gynecol. 2016;128:e111–e130. - PubMed
-
- Patel C., Brotherton J.M., Pillsbury A., Jayasinghe S., Donovan B., Macartney K., Marshall H. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: What additional disease burden will a nonavalent vaccine prevent? Eurosurveill. 2018:23. doi: 10.2807/1560-7917.ES.2018.23.41.1700737. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous